Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Clinical reproductive outcomes

From: Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial

Variable Study group (n = 76) Control group (n = 93) p-value
Number of fresh ET cyclesa, n (%) 66/76 (86.84) 64/93 (68.82) 0.35
Patients who had oocyte retrieval but no ET b, n (%) 6/72 (8.33) 19/83 (22.89) 0.04
Number of FET cycles, n (%) 12/76 (15.79) 3/93 (3.23) 0.01
Patients with cryopreserved embryos, n (%) 14/76 (18.42)c 4/93 (4.30)d 0.012
Number of embryos per ETe, median (IQR) 2 (1,2) 1 (1,2) 0.04
Clinical pregnancy rate per fresh ETf, n (%) 23/66 (34.85) 16/64 (25.00) 0.24
Cumulative clinical pregnancy rateg, n (%) 24/76 (31.58) 16/93 (17.20) 0.11
Multiple pregnancy, n (%) 4/76 (5.26) 3/93 (3.23) 0.70
Spontaneous miscarriage, n (%) 2/23 (8.67) 2/16 (12.50) 0.73
Live birth rate per fresh ETf, n (%) 21/66 (31.82) 14/64 (21.88) 0.33
Cumulative live birth rateg, n (%) 22/76 (28.95) 14/93 (15.54) 0.08
  1. aAll patients with available embryos had fresh ET
  2. bIncluded women who had hCG andoocyte retrieval but did not have oocytes or useable embryos
  3. cEmbryos for 2women from this group did not survive the thawing (2/14, 14.29%)
  4. dEmbryos for 1 woman from this group did not survive the thawing (1/4, 25%)
  5. eAll the transferred embryos were day-3 cleavage stage embryos
  6. fCalculated as follows: the number of clinical pregnancies/ live births originated from fresh ET divided by the number of women with transferred embryos
  7. gCalculated as follows: the number of clinical pregnancies/ live births originated from one completed ART cycle including fresh and frozen-thaw ETs divided by the number of women treated
  8. ET – embryo transfer; FET – frozen-thaw embryo transfer; IQR – interquartile range